Tesamorelin is supplied for laboratory research workflows that require clear product identity, careful handling, and documented specifications.
Research use only. Not for human or veterinary consumption, diagnosis, or treatment.
Weight
0.050 lbs
Quantity
5 MG, 10 MG
📊 Research Dosages and Protocols
Research phase
Research dosage
Administration frequency
Starting / Adaptation
1 mg
Daily (before sleep)
Primary / Maintenance
2 mg
Daily (before sleep)
Maximum exposure
2 mg
Twice daily
* Note: The listed dosages are based on reference research models and should be adapted to the specific requirements of your laboratory protocol.
🧫 Reconstitution and Storage
Reconstitution: Bacteriostatic Water (BAC Water) is recommended. Add it slowly down the side of the vial. Gently swirl the vial without shaking aggressively.
Storage (lyophilized powder): Store in a dark place at -20°C to 4°C.
Storage (reconstituted): After reconstitution, refrigerate at 2°C to 8°C and use within 20–30 days.
🔬 Clinical Study Results
Tesamorelin has been studied for specific medical conditions:
Abdominal fat reduction: Clinical trials reported a 15% to 20% reduction in visceral adipose tissue.
Growth hormone: It stimulates endogenous growth-hormone secretion while preserving normal pulsatile release.
Lipid profile: Improved triglyceride levels were observed in study participants.
* Sold for laboratory research and in vitro models only. The information above summarizes findings reported in published medical literature and human clinical studies.
Frequently asked questions will be added before launch.
